PRKAB2 and neoplasm: In addition to this, when we evaluated PRKAB2 gene expression by multivariate analysis with classic prognostic factors such as patient age and tumor size and volume, we found that this gene was an independent factor in the prognostic prediction of five-year overall and five-year event-free survival rates in pediatric patients with ACTs.